Vaccitech Team
Vaccitech
Last updated: February 23, 2026
Vaccitech is creating novel vaccines that elicit strong responses from helper and cytotoxic T-cells. Healthcare Medical Research
Sequoia, Post-IPO, $290M valuation
Vaccitech is creating novel vaccines that elicit strong responses from helper and cytotoxic T-cells. Healthcare Medical Research
Sequoia, Post-IPO, $290M valuation
- IPO • Sequoia, Post-IPO, $290M valuation
Founder Intelligence Brief: Vaccitech Team
This profile is built to help readers move from a founder name to decision-ready context. Vaccitech Team is mapped to Vaccitech in the Healthcare category, with current stage context as Ipo. The primary operating market is London, England, United Kingdom, which connects this profile directly to regional ecosystem pages and related industry hubs.
Funding visibility currently shows $290.00M, with the latest mapped round as IPO (Sequoia, Post-IPO, $290M valuation). This makes it easier to evaluate growth narrative against capital stage rather than reading isolated updates without baseline context.
For deeper research, combine this founder page with the company profile, company news hub, country newsroom and Healthcare startup list. This route gives a cleaner picture of execution, market demand, and competitive movement.
Research flow
- Validate company baseline on company intelligence.
- Compare market peers via Healthcare industry routes and Ipo stage pages.
- Track fresh updates in newsroom coverage and signals feed.
Operating context
- Geography: United Kingdom directory.
- Stage signal: Ipo funding coverage.
- Hiring status: Open Roles.
Related Founders
More founders in Healthcare.
Want to get featured on 100Xfounder?
Get your founder profile published with verified funding and hiring context.
Related Pillar Pages
Access the country, industry, stage, startup taxonomy, and newsroom routes connected to this founder.
FAQs About Vaccitech Team
Common questions people ask about this profile.
Who is Vaccitech Team?
Vaccitech Team is the founder profile listed on 100Xfounder for Vaccitech, tracked for market signals, company intelligence, and operator-level context.
What does Vaccitech do?
Vaccitech is creating novel vaccines that elicit strong responses from helper and cytotoxic T-cells. Healthcare Medical Research
Where is Vaccitech based?
Vaccitech is listed as operating from London, England, United Kingdom.
What is the current funding stage of Vaccitech?
Vaccitech is currently categorized at Ipo on 100Xfounder. Funding signal: Sequoia, Post-IPO, $290M valuation
What is the latest funding round for Vaccitech?
The latest tracked round for Vaccitech is IPO Sequoia, Post-IPO, $290M valuation. Total tracked rounds: 1.
Is Vaccitech hiring right now?
Current hiring signal for Vaccitech: Open Roles.
Is Vaccitech Team's profile verified?
Yes. Vaccitech Team's profile is marked as verified on 100Xfounder as of March 3, 2026.
How can I connect with Vaccitech Team?
You can use the profile action buttons and listed links on 100Xfounder. Contact context is provided with business relevance and profile metadata for vaccitech.co.uk.
What technologies are associated with Vaccitech?
Vaccitech is associated with Python, GCP, BigQuery, and React based on current profile intelligence.